2018

1. Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

   BMC Cancer, Vol. 18, Núm. 1

2. Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS

   Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1261-1267

3. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

   The Lancet Oncology, Vol. 19, Núm. 4, pp. 521-536